Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial

Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial

Background: Primary biliary cirrhosis (PBC) is an autoimmune liver disease, and 50% of patients with this disease experience fatigue. This is a debilitating symptom affecting quality of life and resulting in social isolation, which is highlighted by patients as a research priority. PBC is characteri...

Full description

Bibliographic Details
Main Authors: Amardeep Khanna, Laura Jopson, Denise Howel, Andrew Bryant, Andrew Blamire, Julia L Newton, Jennifer Wilkinson, Alison J Steel, Jennifer Bainbridge, Renae Stefanetti, Sophie Cassidy, David Houghton, David E Jones
Format: Article
Language:English
Published: NIHR Journals Library 2018-04-01
Series:Efficacy and Mechanism Evaluation
Online Access:https://doi.org/10.3310/eme05020

Internet

https://doi.org/10.3310/eme05020

Similar Items